View of The origin of trimethylamine N oxide (TMAO) and its role in development of atherosclerosis Journal of Food Bioactives Trimethylamine N Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet Journal of Renal Nutrition Pathobiological Relationship of Excessive Dietary Intake of Choline L Carnitine: A TMAO Precursor Associated Aggravation in Heart Failure in Sarcopenic Patients Trimethylamine N oxide (TMAO) is a small molecule produced in humans primarily by the gut liver axis and has become an important biomarker, and possible mediator, of cardiometabolic and renal disease. Dietary choline, phosphatidylcholine ( Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery Microbiome Springer Nature Link